DBV Technologies Announces Results of Viaskin Milk Phase II Study in Milk Allergy Patients ISIN: FR0010417345

Press/Media

Period28 Feb 2018

Media coverage

1

Media coverage

  • TitleDBV Technologies Announces Results of Viaskin Milk Phase II Study in Milk Allergy Patients ISIN: FR0010417345
    Media name/outletPlus Company Updates (PCU)
    Country/TerritoryUnited States
    Date28/02/18
    PersonsKurt Hirschhorn
View all 1
View less